干扰素调节因子1和2基因在人肝癌细胞系中的表达分析

Kazuhiko Nakao , Keisuke Nakata , Manabu Daikoku , Kaoru Inokuchi , Tasuku Nomura , Akio Ido , Shotaro Tsuruta , Yuji Kato , Nobuko Ishii , Shigenobu Nagataki
{"title":"干扰素调节因子1和2基因在人肝癌细胞系中的表达分析","authors":"Kazuhiko Nakao ,&nbsp;Keisuke Nakata ,&nbsp;Manabu Daikoku ,&nbsp;Kaoru Inokuchi ,&nbsp;Tasuku Nomura ,&nbsp;Akio Ido ,&nbsp;Shotaro Tsuruta ,&nbsp;Yuji Kato ,&nbsp;Nobuko Ishii ,&nbsp;Shigenobu Nagataki","doi":"10.1016/0928-4346(96)00268-X","DOIUrl":null,"url":null,"abstract":"<div><p>The transcription activator, Interferon regulatory factor-1 (IRF-1), has been shown to function as a tumor suppressor and the structurally related interferon regulatory factor-2 (IRF-2) as a counterpart. The loss of IRF-1 function or overexpression of IRF-2 are possible mechanisms of cancer development. In the present study, IRF-1 and IRF-2 gene expression was analyzed in human hepatoma cell lines (HuH7, huH 1, HepG2 and PLC/PRF/5) and the normal liver. We found a small amount of exon-skipped IRF-1 mRNA in HuH7 and huH 1, and the low level of IRF-1 mRNA in PLC/PRF/5, but we could not find the overexpression of IRF-2 mRNA in any hepatoma cells lines. Thus, it is possible that hepatocarcinogenesis involves some alterations in expression of IRF-1 gene.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":"4 6","pages":"Pages 351-357"},"PeriodicalIF":0.0000,"publicationDate":"1996-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00268-X","citationCount":"0","resultStr":"{\"title\":\"Analysis of interferon regulatory factor 1 and 2 gene expression in human hepatoma cell lines\",\"authors\":\"Kazuhiko Nakao ,&nbsp;Keisuke Nakata ,&nbsp;Manabu Daikoku ,&nbsp;Kaoru Inokuchi ,&nbsp;Tasuku Nomura ,&nbsp;Akio Ido ,&nbsp;Shotaro Tsuruta ,&nbsp;Yuji Kato ,&nbsp;Nobuko Ishii ,&nbsp;Shigenobu Nagataki\",\"doi\":\"10.1016/0928-4346(96)00268-X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The transcription activator, Interferon regulatory factor-1 (IRF-1), has been shown to function as a tumor suppressor and the structurally related interferon regulatory factor-2 (IRF-2) as a counterpart. The loss of IRF-1 function or overexpression of IRF-2 are possible mechanisms of cancer development. In the present study, IRF-1 and IRF-2 gene expression was analyzed in human hepatoma cell lines (HuH7, huH 1, HepG2 and PLC/PRF/5) and the normal liver. We found a small amount of exon-skipped IRF-1 mRNA in HuH7 and huH 1, and the low level of IRF-1 mRNA in PLC/PRF/5, but we could not find the overexpression of IRF-2 mRNA in any hepatoma cells lines. Thus, it is possible that hepatocarcinogenesis involves some alterations in expression of IRF-1 gene.</p></div>\",\"PeriodicalId\":13746,\"journal\":{\"name\":\"International Hepatology Communications\",\"volume\":\"4 6\",\"pages\":\"Pages 351-357\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0928-4346(96)00268-X\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Hepatology Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/092843469600268X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Hepatology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/092843469600268X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

转录激活因子干扰素调节因子-1 (IRF-1)已被证明作为肿瘤抑制因子和结构相关的干扰素调节因子-2 (IRF-2)作为对应物。IRF-1功能的丧失或IRF-2的过度表达可能是癌症发生的机制。本研究分析了IRF-1和IRF-2基因在人肝癌细胞系(HuH7、huH 1、HepG2和PLC/PRF/5)和正常肝脏中的表达情况。我们在HuH7和huH 1中发现了少量外显子跳过的IRF-1 mRNA,在PLC/PRF/5中发现了低水平的IRF-1 mRNA,但我们没有在任何肝癌细胞系中发现IRF-2 mRNA过表达。因此,肝癌的发生可能与IRF-1基因表达的改变有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Analysis of interferon regulatory factor 1 and 2 gene expression in human hepatoma cell lines

The transcription activator, Interferon regulatory factor-1 (IRF-1), has been shown to function as a tumor suppressor and the structurally related interferon regulatory factor-2 (IRF-2) as a counterpart. The loss of IRF-1 function or overexpression of IRF-2 are possible mechanisms of cancer development. In the present study, IRF-1 and IRF-2 gene expression was analyzed in human hepatoma cell lines (HuH7, huH 1, HepG2 and PLC/PRF/5) and the normal liver. We found a small amount of exon-skipped IRF-1 mRNA in HuH7 and huH 1, and the low level of IRF-1 mRNA in PLC/PRF/5, but we could not find the overexpression of IRF-2 mRNA in any hepatoma cells lines. Thus, it is possible that hepatocarcinogenesis involves some alterations in expression of IRF-1 gene.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信